Pharmacists have been urged caution when dispensing the drug Amoxicillin by manufacturer Accord.
Related Article: Nearly twice as many patients in deprived areas prescribed dependency-forming meds
The class 4 drug alert has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for Amoxicillin 500mg capsules. The relevant batch numbers are MP18062, MP18063, and MP18064, distributed in October last year.
Accord Healthcare Limited said important information about potentially life-threatening side effects was not added to the patient information leaflet for some batches.
Related Article: Finding sustainable funding solution is ‘matter of urgency’ for government
Community pharmacy teams dispensing this drug have been asked to remove the patient information leaflet and provide a copy of the correct version..
They have also been advised to check the Marketing Authorisation Holder and batch number.
Related Article: NICE recommends ‘game changer’ wearable tech for type 1 diabetes
Any patients who have noticed any symptoms have been asked to seek immediate medical advice.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.